What are the key themes of the government’s national health care plan, and what does this mean for the pharmaceuticals industry?
Health
Displaying 163 - 168 of 1326
Interviews & Viewpoints | Rodrigo Puga, Country Manager, Pfizer: Interview from The Report: Mexico 2019
Articles & Analysis | Streamlined government procedures ensure global firms continue to invest in Mexico's pharmaceuticals market from The Report: Mexico 2019
Major global firms continue to invest in Mexico’s pharmaceutical industry. In 2017, 20 of the world’s top-25 pharmaceutical giants were active in the country, and 22.7% of total health spending went towards the pharmaceutical industry, according to the OECD. That same year, Mexico was the second-largest pharmaceutical market in Latin America...
Articles & Analysis | Medical technology leads to improved patient care and cost savings from The Report: Mexico 2019
Rising health care costs, ageing populations and changing lifestyles in emerging economies are stoking demand for medical technology (medtech) solutions. These entail not just smart devices that remotely monitor and transmit biometric data, but any instance of technology that helps to deliver health services. These initiatives are happening...
Although the country is moving closer to achieving its ambitious goal of universal health insurance coverage for all Mexican citizens, some obstacles still remain. The public...
In 2018 Mexico’s economy ranked second in Latin America and 15th in the world in terms of GDP, which totalled $1.22trn, according to the World Bank. In 2019 the newly elected President Andrés Manuel López Obrador has pushed ahead with efforts to meet his pledge to tackle corruption and implement austerity measures within the government, to reduce costs and curb excessive expenditures.
The pharmaceutical industry in Saudi Arabia is set to expand significantly amid government efforts to roll out broad-based reforms to the health care system.